13F manager/ITCI/

John Paulson (Paulson & Co) exit Intra-Cellular Therapies, Inc.

John Paulson (Paulson & Co) exit $-2.8M of disclosed value in Intra-Cellular Therapies, Inc..

Signal
Investor Move
Action
Exit
Capital
$-2.8M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence

John Paulson (Paulson & Co) exit Intra-Cellular Therapies, Inc. | 交易笔记